Patents by Inventor Mathieu Gutmann

Mathieu Gutmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CANCER
    Publication number: 20160237042
    Abstract: Piperazinyl derivatives of formula (I) and their use as a drug, particularly for the treatment of cancer, are disclosed. Also disclosed are pharmaceutical compositions comprising the piperazinyl derivatives, and methods for synthesizing the piperazinyl derivatives.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Denis CARNIATO, Jean-Francois BRIAND, Mathieu GUTMANN, Olivier BUSNEL, Cécile BOUGERET, Benoit DEPREZ, Karine JAILLARDON
  • Compounds which can be used for the treatment of cancers
    Patent number: 8519188
    Abstract: The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: August 27, 2013
    Assignee: Marc-Henry Pitty
    Inventors: Denis Carniato, Karine Jaillardon, Olivier Busnel, Mathieu Gutmann, Jean-Francois Briand, Benoit Deprez, Dominique Thomas, Cécile Bougeret
  • Compounds which can be used for the Treatment of Cancers
    Publication number: 20110104162
    Abstract: The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
    Type: Application
    Filed: June 15, 2009
    Publication date: May 5, 2011
    Applicant: Cytomics Systems
    Inventors: Denis Carniato, Karine Jaillardon, Olivier Busnel, Mathieu Gutmann, Jean-Francois Briand, Benoit Deprez, Dominique Thomas, Cécile Bougeret
  • ANTI-PROLIFERATIVE COMPOUNDS FROM A 3-ARYL-COUMARINE OR 3-ARYL-QUINOLIN-2-ONE AND USES THEREOF
    Publication number: 20090203685
    Abstract: The present invention is directed to molecules deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and having potent anti-proliferative and/or cytotoxic activity, especially against tumoral cells. The present invention also concerns the uses of these molecules in therapeutic application, for the treatment of different cancers. The invention also discloses the use of said compound for the manufacture of a medicament for treating cancer. The invention also concerns a process for inhibiting cell proliferation comprising contacting said cells with a compound of the invention.
    Type: Application
    Filed: May 22, 2007
    Publication date: August 13, 2009
    Applicant: EOS (ETHICAL ONCOLOGY SCIENCE) S.P.A.
    Inventors: Matthieu Schapira, Cyrille Lamigeon, Mathieu Gutmann, Audrey Barthelaix, Nicolas Hugo, Pierre Colas